Sunday - December 22, 2024

Solid Forms of (R)-N-(2-(5-Fluoropyridin-3-Yl)-8-Isopropylpyrazolo[1,5-A] [1,3,5]triazin-4-Yl)-2,3,4,9-Tetrahydro-1h-Carbazol-3-Amine as Aryl Hydrocarbon Receptor (AHR) Inhibitors

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- IKENA ONCOLOGY, INC., Boston, Massachusetts has been assigned a patent (No. US 12162884 B2, initially filed Jan. 19, 2023) developed by four inventors Alfredo C. Castro, Somerville, Massachusetts; James Martin Nolan, III, Boston, Massachusetts; Sarah Jean Bethune, Durham, North Carolina; and Corinne Marie Folberth, Durham, North Carolina, for "Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-car . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Solid Forms of (R)-N-(2-(5-Fluoropyridin-3-Yl)-8-Isopropylpyrazolo[1,5-A] [1,3,5]triazin-4-Yl)-2,3,4,9-Tetrahydro-1h-Carbazol-3-Amine as Aryl Hydrocarbon Receptor (AHR) Inhibitors

Information Request Form

Copyright Targeted News Service 2024